Mubadala Capital

Focus on Biotech Therapeutic Companies

Program

Mubadala Capital is the alternative asset management subsidiary of Mubadala Investment Company, a c. $302 billion global investor headquartered in Abu Dhabi, UAE. Mubadala Capital manages over $27 billion of assets through its four investment businesses spanning various private market strategies, including private equity, special situations, solutions, and venture capital. Mubadala Capital’s team includes over 200 people across five offices, including Abu Dhabi, New York, London, San Francisco and Rio de Janeiro.

Event

LaunchBio, Browne Consulting, and Silicon Valley Bank, a division of First Citizens Bank, are pleased to announce their next Investor Connect virtual event with Mubadala Capital.

Their healthcare ventures team is based in San Francisco and invests in therapeutics-focused biotech and healthcare technology companies. Investing since 2017, its 40 portfolio companies are based across the US and Europe with a focus on early-stage drug development and technologies that improve the delivery of healthcare. Mubadala Capital is a lifecycle investor that supports portfolio companies from seed through to the public markets with a primary focus on private Series A-B investments.

Applications will be selected based on meeting the following criteria:

Geography:
Open to investments globally

Company type:
Focus on therapeutics across neurology, oncology, cardiometabolic, and immunology indications, typically from Seed to Series D

Areas of Interest:

Biologics
CRISPR-based therapies
Gene therapies
Protein-based therapies
Regenerative Medicine
RNA-based therapeutics
Small molecule

Research areas of interest include, but are not limited to:

Open to all target organs/systems and a broad range of therapeutic areas, including cardiology, endocrinology, hematology, oncology, neurology, immunology, pulmonology, and more

Stage:
Companies seeking Series A, Series B, and later-stage funding, specifically those pursuing substantial investment opportunities

Qualifying start-ups can apply here today.

Applications are accepted on a rolling basis. Learn more about LaunchBio’s Investor Connect series, in partnership with Browne Consulting and Silicon Valley Bank, a division of First Citizens Bank.

Bridging the gap between innovation and capital